Virginia AI Laws for Healthcare: What Survived the HB 2094 Veto
Virginia Consumer Data Protection Act, Code of Virginia title 59.1 chapter 53 (sections 59.1-575 to 59.1-585); Code of Virginia sections 38.2-3407.15:2 and 38.2-3407.15:8 on carrier prior authorization as amended by 2026 acts including HB 481; section 32.1-127.1:03 on health records privacy; section 19.2-62 on interception of communications; Board of Medicine regulation 18VAC85-20-26 and guidance document 85-12
Last updated
Need it signed off?
Thirty free minutes with an analyst on the vendor, the workflow and the rule you are unsure about.
Book an evaluation callRegulator
Virginia Attorney General for the Consumer Data Protection Act; State Corporation Commission Bureau of Insurance for carrier prior authorization rules; Department of Health Professions boards for licensee conduct
Who it applies to
- Health carriers issuing prior authorization decisions in Virginia, which from July 1, 2026 may not make an adverse determination without review and approval by a licensed physician or the named fallback professional
- Controllers and processors that conduct business in Virginia and control or process personal data of at least 100,000 Virginia consumers a year, or 25,000 consumers while deriving over 50 percent of gross revenue from data sales, unless exempt as a HIPAA covered entity or business associate
- AI vendors that are not business associates, such as consumer wellness, marketing, recruitment and analytics tools, which can fall inside the VCDPA even when their health care customers are exempt
- Every health care entity as defined in section 32.1-127.1:03, which reaches all professionals licensed by a Department of Health Professions board, health plans and clearinghouses, regardless of HIPAA status
- Physicians, physician assistants, nurse practitioners and other Board of Medicine and Board of Nursing licensees, who owe the records and telemedicine duties in 18VAC85-20-26 and guidance documents 85-12 and 90-64
- Anyone recording or transcribing a conversation in Virginia, for whom section 19.2-62 requires consent of at least one party to the communication
- Commonwealth agencies and their suppliers, which are bound by Executive Order 30 and the Virginia IT Agency AI standard; private providers are not
Penalties
There is no AI specific penalty regime in Virginia because there is no AI specific statute. Under the Consumer Data Protection Act, section 59.1-584, the Attorney General has exclusive enforcement authority, must give 30 days written notice and an opportunity to cure, and may then seek civil penalties of up to 7,500 dollars for each violation plus investigation expenses and attorney fees; the Act expressly provides no private right of action. Carrier prior authorization duties in sections 38.2-3407.15:2 and 38.2-3407.15:8 are enforced by the State Corporation Commission Bureau of Insurance through its general powers over licensed carriers. Unlawful interception of a communication under section 19.2-62 is a Class 6 felony. Breaches of the health records privacy statute, section 32.1-127.1:03, and of the Board of Medicine's records regulation, 18VAC85-20-26, are pursued as unprofessional conduct against the licensee by the Department of Health Professions boards, which can reprimand, fine, restrict, suspend or revoke a licence.
Deadlines
Dates that already bind, and dates still ahead.
| Date | What happens |
|---|---|
| The Virginia Consumer Data Protection Act took effect (2021 Special Session I, chapters 35 and 36). HIPAA covered entities and business associates are exempt at the entity level; protected health information is exempt at the data level. | |
| Executive Order 30 directed state agencies to adopt AI standards administered by the Virginia IT Agency. It binds Commonwealth agencies and their suppliers, not private providers. | |
| VCDPA amendments on the personal data of known children under 13 took effect (2024 chapters 840 and 844). | |
| Governor Youngkin vetoed HB 2094, the High-Risk Artificial Intelligence Developer and Deployer Act. The House sustained the veto on April 2, 2025. | |
| Carriers were required under section 38.2-3407.15:2 to maintain an online prior authorization process linking to e-prescribing and EHR systems that can approve requests needing no clinical review. | |
| The 2026 regular session adjourned. SB 586 on carrier AI disclosures, SB 269 on AI in mental health services and SB 796 on chatbots and minors were continued to the 2027 session in the House. | |
| HB 481 took effect. No carrier may make an adverse prior authorization determination unless a licensed physician, or a named fallback professional, has reviewed and approved it. | |
| The current versions of sections 38.2-3407.15:2 and 38.2-3407.15:8, including API based electronic prior authorization requirements, become fully effective. |
What changed in 2026
Movement by year, newest first. Where nothing in the text moved, that is recorded too.
2026
The 2026 session was expected to produce a health care only successor to HB 2094. It did not. Delegate Maldonado said before the session that the reintroduced bill would be limited to the health care sector with impact assessments, disclosure and an appeal route for AI driven adverse decisions. As of September 2026 we could not confirm a bill number for that measure on lis.virginia.gov, and reporting from the session records that the House Communications, Technology and Innovation Committee carried most AI bills over to 2027 after a federal executive order threatened broadband funding for states with what it called onerous AI laws.
What the record does show for health care is this. SB 586, which would require health carriers to disclose to the Bureau of Insurance how AI is used to manage claims coverage, passed the Senate 23 to 16 and was continued to 2027 in the House. SB 269 and its House companion HB 668, which would permit AI for administrative support in mental health services while prohibiting AI therapy or counselling without a licensed provider in control, passed the Senate 39 to 0 and were continued to 2027; the House bill was left in committee. SB 796, on chatbots and minors, passed the Senate and was continued. SB 500, which would have required carriers to disclose the use of any AI based tool in a prior authorization denial and shortened decision timeframes, was introduced; its AI disclosure language does not appear in the enacted code sections as of September 2026 and we could not confirm its final disposition on a primary source.
Two AI bills did pass: HB 797 and SB 384, creating an AI safety advisory function under the Virginia IT Agency, and HB 580, extending the Division of Consumer Counsel's duties to AI fraud and abuse. Neither imposes duties on a provider.
The enacted change that matters to a clinic is HB 481, effective July 1, 2026. It amends sections 38.2-3407.15:2 and 38.2-3407.15:8 so that no carrier may make an adverse prior authorization determination for prescription drugs unless a licensed physician, or if none is available a licensed pharmacist, has reviewed and approved it, and none for health care services unless a licensed physician, or for mental health a licensed mental health provider and for dental a licensed dentist where a physician is unavailable, has done so. The statute does not mention AI. It does make a fully automated denial unlawful in Virginia, which is the practical outcome most AI utilization review bills elsewhere aim at. HB 736, signed April 8, 2026, separately lengthened drug prior authorization durations.
2025
Virginia came within one signature of being the second state with a Colorado style AI act. HB 2094, the High-Risk Artificial Intelligence Developer and Deployer Act, passed the General Assembly in February and March 2025. It would have required developers and deployers of high risk AI systems, including those materially influencing decisions about health care services, to use reasonable care against algorithmic discrimination, run impact assessments, and give consumers notice, an explanation and a right to correct and appeal, with Attorney General enforcement and civil penalties.
Governor Youngkin vetoed it on March 24, 2025, citing the burden on the AI industry and on smaller firms, and the House sustained the veto on April 2, 2025. Nothing in it took effect. Commentary that still describes Virginia as having a high risk AI framework is describing a bill that died.
In the same year the Attorney General joined a 44 state coalition letter of August 29, 2025 warning large technology companies about chatbot harms to minors. That is a signal of enforcement interest, not guidance for health care providers, and no Virginia Attorney General guidance specific to AI in health care had been published as of September 2026.
2024
Executive Order 30, signed January 18, 2024, set standards for the safe use of AI across Commonwealth agencies. The Virginia IT Agency now publishes an Artificial Intelligence Standard and an AI Utilization Policy, and agencies must register AI uses and obtain agency head approval. The order and the standard apply to state agencies and their suppliers. A private hospital or practice is not bound, but a vendor selling into a state facility, a state university health system or Medicaid operations is, and that is a reasonable benchmark to hold any vendor to.
The General Assembly also amended the VCDPA in 2024 (chapters 840 and 844) to restrict processing of a known child's data, effective January 1, 2025, and continued its multi year prior authorization reform in title 38.2, adding the online electronic prior authorization process that carriers had to operate from July 1, 2025.
Is there a Virginia AI law that applies to healthcare providers?
No. Virginia has no statute of general application that regulates the development or deployment of AI, and none aimed at AI in clinical care.
That is not for lack of trying. HB 2094 passed both chambers in early 2025. It defined a high risk AI system as one that is a substantial factor in a consequential decision, and consequential decisions included the provision or denial of health care services. Deployers would have owed a duty of reasonable care against algorithmic discrimination, an impact assessment before deployment and on material change, pre decision notice to the consumer, and after an adverse decision a statement of the principal reasons, a chance to correct data and an appeal with human review. The Attorney General would have enforced it with civil penalties. Governor Youngkin vetoed it on March 24, 2025 and the veto was sustained on April 2, 2025.
The 2026 session then carried the successor bills to 2027 rather than passing them, as set out in the What changed section above. So the honest answer for a Virginia practice manager or CMIO in September 2026 is that the AI specific duties you see in Colorado, Texas and California have no Virginia counterpart. A vendor telling you its product is Virginia AI Act compliant is describing nothing.
What you have instead is a set of older laws that reach AI deployments because they reach the underlying activity: prior authorization, personal data, health records, recording and the practice of medicine. The rest of this page walks through each of them, then gives the checklist for this year. If you operate in several states, our state by state map and the healthcare AI law checker put Virginia next to the states that did legislate.
What does HB 481 do to AI in prior authorization from July 2026?
It makes a fully automated denial unlawful without ever saying the words artificial intelligence.
HB 481, effective July 1, 2026, amended section 38.2-3407.15:2 so that no carrier shall make an adverse determination of a prior authorization request for prescription drugs unless that determination has been reviewed and approved by a licensed physician or, if a licensed physician is not available, a licensed pharmacist. It amended section 38.2-3407.15:8 in parallel for health care services: review and approval by a licensed physician, or in mental health by a licensed mental health provider and in dental by a licensed dentist where a physician is unavailable. The current code text of both sections, which carry a January 1, 2027 effective date for their full API based electronic prior authorization requirements, contains that language and no reference to AI.
Read against payer practice, this is the same outcome that California's SB 1120 reaches by name. An algorithm can triage, score, draft and recommend. A licensed human must review and approve before a Virginia enrollee receives a denial. Two limits matter. First, the statute regulates carriers licensed in Virginia under title 38.2; self funded ERISA plans, Medicare Advantage and Medicaid managed care follow their own rules, including the CMS interoperability and prior authorization final rule. Second, it does not require the carrier to tell you an AI tool was used. SB 500 would have added that disclosure to the enrollee and the provider, together with 24 hour and five day decision windows and a gold card exemption for providers with high approval rates. Its AI language is not in the enacted code as of September 2026, and we could not confirm its final disposition on lis.virginia.gov, so treat it as not law.
For the provider side, section 38.2-3407.15:2 has required carriers since July 1, 2025 to run an online prior authorization process that links to e-prescribing and EHR systems and can approve requests that need no clinical review. That is the channel prior authorization automation should be built against, rather than portal scraping or fax. Ask your vendor which Virginia carriers it reaches through that process and which still require manual work.
Does the Virginia Consumer Data Protection Act reach your AI vendors?
Not the ones that sign a business associate agreement with you. Possibly the ones that do not, and that is where the exposure sits.
The VCDPA, Code of Virginia sections 59.1-575 to 59.1-585, has applied since January 1, 2023 to persons conducting business in Virginia that control or process personal data of at least 100,000 consumers a year, or 25,000 consumers while deriving over half of gross revenue from selling personal data. Section 59.1-576 then exempts a covered entity or business associate governed by the HIPAA privacy, security and breach notification rules at the entity level, and separately exempts protected health information, health records under title 32.1, HIPAA de-identified data, patient safety work product and human subjects research data at the data level. A hospital, practice or scribe vendor operating under a BAA is outside the Act for that work.
The gaps are practical rather than theoretical.
- Vendors that never become business associates. A consumer facing symptom checker, a wellness app you recommend, a recruitment screening tool, a marketing analytics platform or a chatbot on a public website that collects health information before any patient relationship exists is processing personal data, and under section 59.1-575 personal data revealing mental or physical health diagnosis is sensitive data. Section 59.1-578 requires consent before processing sensitive data.
- Profiling and significant decisions. The Act defines profiling to include automated processing to predict a person's health, and gives consumers an opt out from profiling in furtherance of decisions that produce legal or similarly significant effects, a list that expressly includes health care services. An AI tool that scores non patients, for example for outreach or eligibility, sits inside that language.
- Data protection assessments. Section 59.1-580 requires a controller to conduct and document a data protection assessment for processing sensitive data and for profiling that presents a reasonably foreseeable risk of unfair treatment or other substantial injury. The Attorney General can demand it.
Enforcement under section 59.1-584 is by the Attorney General alone, with 30 days written notice and cure, then up to 7,500 dollars per violation. There is no private right of action. The Act has been amended in 2022, 2024 and 2025; the 2025 amendment, chapter 703, is listed on law.lis.virginia.gov as effective September 1, 2026, so check the current text of any section you rely on. For the vendor questions that flush this out before signature, use the questions to ask AI vendors and read the HIPAA and AI page, because in Virginia HIPAA is still doing most of the work.
What does Virginia health records law add on top of HIPAA?
A state law duty of confidentiality that attaches to every licensed professional, not only to HIPAA covered entities, and a records standard that an AI scribe has to meet.
Section 32.1-127.1:03 states that no health care entity may disclose an individual's health records except as the section permits. A health care entity is defined to include every health care provider licensed by a Department of Health Professions board, health plans and clearinghouses. A health record is any written, printed or electronically recorded material maintained by a health care entity in the course of providing health services, together with confidential communications acquired in treatment. Disclosure for treatment, payment and health care operations is permitted, which is how an ambient scribe vendor acting on your behalf fits, but the statute is the reason a Virginia licensee cannot rely on a HIPAA gap. A cash only practice, a small counselling office that does not transact electronically, or a clinician using a personal AI tool outside the organisation's contracts is still bound.
The Board of Medicine's records regulation, 18VAC85-20-26, requires practitioners to maintain timely, accurate, legible and complete patient records, to comply with section 32.1-127.1:03, and to keep records for at least six years after the last patient encounter, longer for minors. Two consequences for AI medical scribes follow. The signed note is the practitioner's record and the practitioner is answerable for its accuracy, so a draft must be reviewed before it is filed. And the six year retention applies to the record you keep, not to the vendor's audio or transcript, so decide in the contract whether audio is retained, for how long and who can produce it in a complaint or a malpractice claim.
The Board had published no guidance document on AI as of September 2026. Its guidance document list includes 85-5 on medical records questions and 85-12 on telemedicine, and the Board of Nursing publishes 90-64 for nurse practitioners. Absent AI guidance, the Board will assess AI assisted documentation exactly as it assesses any other documentation: through the record and the licensee's signature on it. A written practice AI policy that says who reviews AI output, how and before what point is the evidence you will want if a record is ever questioned.
What do AI phone agents and scribes trigger under Virginia consent and telemedicine rules?
Less than in California, and more than nothing.
Recording. Section 19.2-62 makes it lawful to intercept a wire, electronic or oral communication where the person is a party to it or one party has given prior consent. Virginia is a one party consent state, and a violation is a Class 6 felony. Because the practice is a party to its own calls and visits, an AI phone agent recording inbound calls or an ambient scribe capturing a visit does not need the patient's consent under Virginia criminal law. Three reasons to obtain it anyway: callers in all party consent states such as Maryland, Pennsylvania and California are protected by their own law when they call you; the Board of Medicine's telemedicine guidance expects express consent before patient identifiable information is forwarded to a third party; and patients who discover recording after the fact complain to boards, not to statute books.
Telemedicine. Virginia has no statute defining telemedicine consent for clinicians. Section 38.2-3418.16 defines telemedicine services for coverage purposes and excludes audio only telephone, email, fax and online questionnaires on their own. Board of Medicine guidance document 85-12, revised October 28, 2018, fills the gap. It expects documented informed consent that identifies the practitioner and credentials, lists the activities permitted through telemedicine, describes security measures and residual privacy risk, and includes a requirement for express patient consent to forward patient identifiable information to a third party. It also expects written policies naming the health care personnel, in addition to the practitioner, who will process messages, and requires copies of patient practitioner electronic communications to be kept in the record.
Map that onto AI. An AI intake or triage agent handling patient messages is personnel who process messages in the sense of 85-12 and belongs in the written policy. A scribe vendor is a third party receiving patient identifiable information and belongs in the consent. A telehealth platform that transcribes visits needs the transcript, or a note derived from it, in the record. None of this is onerous. All of it is missing from most vendor onboarding packs, which is why an independent check of the consent and policy set before go live is worth more in Virginia than a legal opinion on a statute that does not exist.
Does Executive Order 30 or the state AI standard bind a private provider?
No, and it is still worth reading.
Executive Order 30 of January 18, 2024, Implementation of Standards for the Safe Use of Artificial Intelligence Across the Commonwealth, directed the Virginia IT Agency to set standards for AI use by state government. The result is an Artificial Intelligence Standard and an AI Utilization Policy covering existing and new uses, stand alone, embedded and generative AI. Agencies register each AI use in the Commonwealth's technology portfolio and need approval from the agency IT resource, information security officer, agency head and cabinet secretary before deployment. The agency publishes bias assessment, vendor evaluation and incident response templates. The scope statement is Commonwealth agencies and suppliers.
Three situations pull a private organisation in. If you are a supplier to a state agency, a state teaching hospital or a Medicaid programme, your product is subject to the standard through the contract. If you are a vendor selling to Virginia's public universities, a separate higher education registration process applies. And if you are a private health system negotiating with a vendor that also sells to the Commonwealth, the vendor has already produced the bias assessment and inventory entries the state demanded, so ask for them.
The 2026 session added HB 797 and SB 384, which set up an AI safety advisory function under the Virginia IT Agency to evaluate frameworks for independent verification of AI model safety and credibility, and HB 580, which added AI fraud and abuse programmes to the Division of Consumer Counsel in the Attorney General's office. Neither imposes duties on a provider. Both indicate where Virginia guidance, if any comes before 2027, will be published. The federal baseline in HIPAA and AI and the NIST AI Risk Management Framework the state standard draws on remain the documents to build to.
What is pending in Virginia, and should you build for it now?
Four measures were carried to the 2027 session and one was promised but not filed in a form we could confirm. Build for the parts that cost nothing to have early; do not build for the rest.
| Measure | What it would do | Status as of September 2026 |
|---|---|---|
| SB 586 (Salim) | Health carriers disclose to the Bureau of Insurance how AI is used to manage claims coverage and submit the information enabling AI decisions | Passed Senate 23 to 16; continued to 2027 in the House |
| SB 269 (Favola) and HB 668 (Maldonado) | Permit AI for administrative and supplementary support in mental health services; prohibit AI therapy or counselling without a licensed provider maintaining control | SB 269 passed Senate 39 to 0, continued to 2027; HB 668 left in House committee |
| SB 796 | Rules for AI chatbots used by minors | Passed Senate; continued to 2027 in the House |
| SB 500 | Carrier must disclose any AI based tool used in a prior authorization denial; 24 hour and 5 day decision windows; gold card exemption | Introduced; AI language not in enacted code; final disposition not confirmed on a primary source |
| Health care high risk AI bill (Maldonado) | Narrowed HB 2094: impact assessments, disclosure and appeal for AI in consequential health care decisions | Announced for 2026; bill number not confirmed on lis.virginia.gov; treat as not filed or continued |
Two of these are worth acting on now because the action is free. If you run a behavioural health service, adopt the SB 269 posture voluntarily: AI for scheduling, documentation and admin, no AI delivering therapy or counselling without a licensed provider in control of the session. That is already the rule in Colorado and Utah and it is the direction of every board in the country. And if you receive prior authorization denials, start recording whether the carrier disclosed AI involvement, because SB 500 style disclosure is the next step after HB 481 and your data will be the evidence for it.
Do not build an HB 2094 impact assessment programme on the assumption the bill returns in the same form. The federal pressure that stalled the 2026 bills has not lifted, the 2027 text will differ, and the artefacts you would need, an inventory, a risk assessment per system and a human review path, are the same ones Colorado already requires if you operate there. Build those once for the state that binds you and Virginia is covered when it legislates.
If you deploy AI in a Virginia clinic in 2026, do these things
Seven items, ordered by how soon each one can hurt you.
- Put every AI vendor into one of two boxes: business associate or VCDPA controller. A BAA takes the vendor and the data outside the Consumer Data Protection Act. A vendor with no BAA that touches health related data of Virginia residents needs consent for sensitive data, a data protection assessment and an opt out route under sections 59.1-578 and 59.1-580. Marketing, recruitment and public website chatbots are the usual misses.
- Gate AI drafted notes behind clinician review and signature. 18VAC85-20-26 makes the practitioner responsible for timely, accurate and complete records. Configure the scribe so no draft files unsigned, and write the review step into policy.
- Update telemedicine and visit consent for third parties. Guidance document 85-12 expects express consent before patient identifiable information goes to a third party. Name the scribe and any AI agent category in the consent and in the written policy that lists who processes messages.
- Announce recording on calls even though Virginia is one party consent. Section 19.2-62 protects you in Virginia; it does not protect you from a Maryland or Pennsylvania caller's law, and an announced recording avoids the board complaint.
- Decide audio and transcript retention in the contract. Your record must be kept six years. Decide separately whether the vendor keeps audio at all, for how long, and how it is produced in a complaint or claim.
- Log AI involvement in every prior authorization denial you receive. HB 481 requires a licensed physician or named fallback to have approved the denial from July 1, 2026. Where a denial looks automated, request the reviewer's identity and credential in the appeal and report patterns to the Bureau of Insurance.
- Hold vendors to the Commonwealth's own AI standard. Ask for the bias assessment, inventory entry and incident response plan the Virginia IT Agency requires of state suppliers. A vendor that sells to the state has them; one that does not should be able to produce equivalents.
Virginia's position is unusual: it is one veto and one carried over session away from a Colorado style regime, and in the meantime its obligations are scattered across insurance, privacy, records and criminal law rather than collected in one place. That scattering is where practices fail, because no single owner sees all of it. Our AI governance and compliance engagement builds the inventory, the vendor classification and the consent and policy set once, mapped to Virginia today and to the 2027 bills as they move. It usually starts with an AI readiness audit of what is already running. Book a call if you would rather have that done before the next session opens than after.
Official sources
Primary documents from the issuing authority. Where a summary and the source disagree, the source is right.
- StateHB 2094, High-Risk Artificial Intelligence Developer and Deployer Act, 2025 session, Virginia Legislative Information System (opens in a new tab)
- StateHB 481, prior authorization, physician review for denial, 2026 session enrolled text, Virginia Legislative Information System (opens in a new tab)
- StateSB 586, health carriers, artificial intelligence disclosures, 2026 session, Virginia Legislative Information System (opens in a new tab)
- StateSB 500, prior authorization for health care services, 2026 session, Virginia Legislative Information System (opens in a new tab)
- StateSB 269, artificial intelligence in mental health services, 2026 session, Virginia Legislative Information System (opens in a new tab)
- StateCode of Virginia section 38.2-3407.15:8, carrier contracts, prior authorization for health care services (opens in a new tab)
- StateCode of Virginia section 38.2-3407.15:2, carrier contracts, prior authorization for drug benefits (opens in a new tab)
- StateCode of Virginia section 59.1-576, Consumer Data Protection Act, scope and exemptions (opens in a new tab)
- StateCode of Virginia section 59.1-584, Consumer Data Protection Act, enforcement and civil penalty (opens in a new tab)
- StateCode of Virginia section 32.1-127.1:03, health records privacy (opens in a new tab)
- StateCode of Virginia section 19.2-62, interception of wire, electronic or oral communications (opens in a new tab)
- State18VAC85-20-26, patient records, Board of Medicine (opens in a new tab)
- StateBoard of Medicine guidance documents, including 85-12 Telemedicine, Virginia Department of Health Professions (opens in a new tab)
- StateArtificial intelligence standards under Executive Order 30, Virginia IT Agency (opens in a new tab)
- StateAttorney General joins 44 state coalition letter on AI chatbots, August 29, 2025, Office of the Attorney General of Virginia (opens in a new tab)
- NISTAI Risk Management Framework, NIST (opens in a new tab)
Questions we get asked
Does Virginia have an AI law like Colorado's?
No. HB 2094, the High-Risk Artificial Intelligence Developer and Deployer Act, would have been the second Colorado style statute in the country. It passed the General Assembly in 2025, was vetoed by Governor Youngkin on March 24, 2025, and the House sustained the veto on April 2, 2025. A narrower health care version was promised for 2026 but the House carried the session's AI bills to 2027. Virginia has no general AI statute as of September 2026.
Can a Virginia insurer use AI to deny prior authorization?
It can use AI in the review, but since July 1, 2026 HB 481 prohibits a carrier from making an adverse prior authorization determination unless a licensed physician has reviewed and approved it, with a licensed pharmacist as the fallback for drugs and a licensed mental health provider or dentist as the fallback for those services. The statute does not require the carrier to disclose that an AI tool was used; SB 500 proposed that and its language is not in the enacted code. See the CMS prior authorization rule for federal plans.
Does the Virginia Consumer Data Protection Act apply to my practice?
Almost certainly not to the practice itself. Section 59.1-576 exempts HIPAA covered entities and business associates at the entity level and protected health information at the data level. It can apply to AI vendors you use that are not business associates, such as consumer facing chatbots, wellness apps, marketing analytics or recruitment tools, once they meet the 100,000 consumer threshold. Health diagnosis data is sensitive data requiring consent under the Act.
Do I need patient consent to use an AI scribe in Virginia?
Virginia is a one party consent state under section 19.2-62, so recording a visit you are party to is lawful without the patient's consent. Board of Medicine guidance document 85-12 nonetheless expects express patient consent before patient identifiable information is forwarded to a third party, and the scribe vendor is a third party. The practical answer is to disclose the scribe, offer an opt out and document the consent in the record, which also protects you with out of state telehealth patients.
Has the Virginia Board of Medicine issued guidance on AI?
Not as of September 2026. The Board's guidance document list includes 85-5 on medical records and 85-12 on telemedicine, and the Board of Nursing has 90-64 on telemedicine for nurse practitioners, but nothing on AI. The Board's existing records regulation, 18VAC85-20-26, requires timely, accurate, legible and complete records kept for six years, and that is the standard an AI assisted note will be judged against. A written practice AI policy is the sensible interim step.
Is Executive Order 30 relevant to a private hospital?
Only indirectly. Executive Order 30 of January 18, 2024 and the Virginia IT Agency's AI standard bind Commonwealth agencies and their suppliers. A private hospital is not covered, but a vendor that also sells to the state has produced the bias assessment, inventory entry and incident response plan the standard demands, and you can ask for the same documents in your own procurement.
What Virginia AI bills should I watch for 2027?
SB 586 on carrier AI disclosures to the Bureau of Insurance, SB 269 and HB 668 on AI in mental health services, SB 796 on chatbots and minors, and any reintroduction of the health care limited high risk AI bill Delegate Maldonado described before the 2026 session. Check lis.virginia.gov once the 2027 session opens in January, or use our healthcare AI law checker and state AI laws map, which we update as bills move.
Make it a formal evaluation
Everything we publish is free to read and free to argue with. When the decision has to be signed, dated and defended to a board, we run the evaluation against your own estate. We take no vendor commissions.
- A 30 minute evaluation call with an analyst, no pitch deck.
- A read on the vendors and the rules in play, and the use cases we would not touch yet.
- A written proposal with scope, sequence and a fixed fee.
- No obligation
- Direct with an analyst, not a sales rep
- BAA available before any PHI discussion